Zevra Therapeutics (ZVRA) Leases (2018 - 2025)
Historic Leases for Zevra Therapeutics (ZVRA) over the last 10 years, with Q3 2025 value amounting to $1.3 million.
- Zevra Therapeutics' Leases rose 6304.88% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 6304.88%. This contributed to the annual value of $1.0 million for FY2024, which is 0.0% changed from last year.
- Per Zevra Therapeutics' latest filing, its Leases stood at $1.3 million for Q3 2025, which was up 6304.88% from $1.5 million recorded in Q2 2025.
- Zevra Therapeutics' 5-year Leases high stood at $1.6 million for Q1 2025, and its period low was $698000.0 during Q3 2023.
- Its 5-year average for Leases is $1.1 million, with a median of $1.1 million in 2024.
- In the last 5 years, Zevra Therapeutics' Leases tumbled by 3464.42% in 2023 and then skyrocketed by 6421.51% in 2025.
- Quarter analysis of 5 years shows Zevra Therapeutics' Leases stood at $1.1 million in 2021, then fell by 13.41% to $988000.0 in 2022, then increased by 4.35% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then grew by 29.68% to $1.3 million in 2025.
- Its Leases was $1.3 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.6 million in Q1 2025.